Johnson & Johnson shares fall following third-quarter earnings release
JNJ Johnson & Johnson
$259.36 +2.19%
View chart & analysis → - 1Johnson & Johnson (JNJ) shares fell sharply after announcing third-quarter results
- 2Revenue rose 5.9% to $25.4 billion, while adjusted earnings per share fell 7.5% to $2.59, and medtech sales grew 2.5% to $8.6 billion
- 3The company slightly raised its fiscal year 2026 revenue guidance to a midpoint of $100.7 billion, and sluggish medtech performance was the main reason for the share decline
So what's the key point?
Johnson & Johnson's stock price dropped because the medical device segment underperformed despite an increase in overall revenue. However, the company slightly raised its revenue outlook for this year.
Source The Motley Fool +1 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.